Related Experiment Video
Updated: May 7, 2026

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
Published on: January 30, 2014
Interleukin-13/Interleukin-4-induced oxidative stress contributes to death of prothrombinkringle-2 (pKr-2)-activated
So-Yoon Won1, Sang Ryong Kim, Sungho Maeng
1Department of Biochemistry and Medical Research Center, Chungbuk National University College of Medicine, Cheongju 361-763, South Korea.
Abstract:
The present study examined whether Interleukin-13 (IL-13) or IL-4, an anti-inflammatory cytokine, could induce cell death of activated microglia by prothrombin kringle-2 (pKr-2) which is a domain of prothrombin distinct from thrombin. Microglia cell death was detected at eight days after co-treatment of pKr-2 with IL-13/IL-4 in vitro. This cell death was assessed by live assay, dead assay, TUNEL and MTT assay. In parallel, reactive oxygen species (ROS) production was evident as assessed by superoxide assay, WST-1 and analyzing DCF in combination of pKr-2 and IL-13 or IL-4 treated microglia. The IL-13/IL-4-enhanced ROS production and cell death in pKr-2 activated microglia was partially inhibited by an NADPH oxidase inhibitor, apocynin and/or by several antioxidants. Moreover, Western blot analysis showed a significant increase in cyclooxygenase-2 (COX-2) expression in combination of pKr-2 and IL-13 or IL-4 treated microglia, which was partially inhibited by apocynin and an antioxidant, trolox. Additional studies demonstrated that microglia cell death was reversed by treatment with COX-2 inhibitor, NS398. Our data strongly suggest that oxidative stress and COX-2 activation through NADPH oxidase may contribute to IL-13/IL-4 induced cell death of pKr-2 activated microglia.
Insights
Interleukin-13 (IL-13) and IL-4 induce microglia cell death via prothrombin kringle-2 (pKr-2) by increasing reactive oxygen species (ROS) and cyclooxygenase-2 (COX-2) expression. Oxidative stress and COX-2 activation contribute to this cell death.
Area of Science:
- Neuroimmunology
- Cell Biology
- Biochemistry
Background:
- Microglia play crucial roles in brain immunity and disease.
- Prothrombin kringle-2 (pKr-2) is a distinct domain of prothrombin.
- Interleukin-13 (IL-13) and IL-4 are anti-inflammatory cytokines.
Purpose of the Study:
- To investigate if IL-13 or IL-4 induce cell death in activated microglia treated with pKr-2.
- To elucidate the mechanisms underlying pKr-2 and cytokine-induced microglia cell death.
Main Methods:
- In vitro co-treatment of activated microglia with pKr-2 and IL-13/IL-4.
- Assessment of cell death using live/dead assays, TUNEL, and MTT assays.
- Measurement of reactive oxygen species (ROS) and cyclooxygenase-2 (COX-2) expression.
Main Results:
- Co-treatment of pKr-2 with IL-13/IL-4 induced microglia cell death.
- Increased ROS production and COX-2 expression were observed.
- Inhibition of NADPH oxidase and antioxidants partially reduced ROS and cell death.
- COX-2 inhibition reversed microglia cell death.
Conclusions:
- Oxidative stress and COX-2 activation via NADPH oxidase contribute to IL-13/IL-4 induced microglia cell death.
- pKr-2 in combination with IL-13/IL-4 triggers a pathway leading to microglia apoptosis.
Related Concept Videos
Inflammation
Cellular Injury IlI: Cellular Death
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
The Extrinsic Apoptotic Pathway